|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-3-7
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Interferon reportedly decreases the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial showed that 4 years of maintenance therapy with pegylated interferon (peginterferon) does not reduce liver disease progression. We investigated whether peginterferon decreases the incidence of HCC in the HALT-C cohort over a longer posttreatment follow-up period.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/1 UL1 RR 025780-01,
http://linkedlifedata.com/resource/pubmed/grant/1 UL1 RR024986,
http://linkedlifedata.com/resource/pubmed/grant/1 UL1 RR025758-01,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00042,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00043,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00051,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00065,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00633,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00827,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-01066,
http://linkedlifedata.com/resource/pubmed/grant/M01RR-06192,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327,
http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328,
http://linkedlifedata.com/resource/pubmed/grant/RR024982-01,
http://linkedlifedata.com/resource/pubmed/grant/UL1 RR024986-02,
http://linkedlifedata.com/resource/pubmed/grant/UL1 RR024986-03
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1528-0012
|
|
pubmed:author |
pubmed-author:BonkovskyHerbert LHL,
pubmed-author:Di BisceglieAdrian MAM,
pubmed-author:DienstagJules LJL,
pubmed-author:EverhartJames EJE,
pubmed-author:EversonGregory TGT,
pubmed-author:GhanyMarc GMG,
pubmed-author:HALT-C Trial Group,
pubmed-author:KimHae-YoungHY,
pubmed-author:LeeWilliam MWM,
pubmed-author:LindsayKaren LKL,
pubmed-author:LokAnna SAS,
pubmed-author:MorganTimothy RTR,
pubmed-author:MorishimaChihiroC,
pubmed-author:SterlingRichard KRK,
pubmed-author:WrightElizabeth CEC
|
|
pubmed:copyrightInfo |
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
840-9; quiz e12
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21129375-Humans,
pubmed-meshheading:21129375-United States,
pubmed-meshheading:21129375-Incidence,
pubmed-meshheading:21129375-Liver Cirrhosis,
pubmed-meshheading:21129375-Biopsy,
pubmed-meshheading:21129375-Liver Neoplasms,
pubmed-meshheading:21129375-Female,
pubmed-meshheading:21129375-Male,
pubmed-meshheading:21129375-Treatment Outcome,
pubmed-meshheading:21129375-Adult,
pubmed-meshheading:21129375-Polyethylene Glycols,
pubmed-meshheading:21129375-Carcinoma, Hepatocellular,
pubmed-meshheading:21129375-Middle Aged,
pubmed-meshheading:21129375-Time Factors,
pubmed-meshheading:21129375-RNA, Viral,
pubmed-meshheading:21129375-Antiviral Agents,
pubmed-meshheading:21129375-Disease Progression,
pubmed-meshheading:21129375-Risk Factors,
pubmed-meshheading:21129375-Risk Assessment,
pubmed-meshheading:21129375-Drug Administration Schedule,
pubmed-meshheading:21129375-Viral Load,
pubmed-meshheading:21129375-Recombinant Proteins,
pubmed-meshheading:21129375-Interferon-alpha,
pubmed-meshheading:21129375-Proportional Hazards Models,
pubmed-meshheading:21129375-Hepacivirus,
pubmed-meshheading:21129375-Kaplan-Meier Estimate
|
